128 related articles for article (PubMed ID: 38785457)
1. The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review.
Quan T; Cockburn J; Dhesy-Thind S; Bane A; Leong H; Geleff C; Devion C; Ajel N; Jerzak KJ
Curr Oncol; 2024 Apr; 31(5):2364-2375. PubMed ID: 38785457
[TBL] [Abstract][Full Text] [Related]
2. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
4. Prediction of binding affinity and efficacy of thyroid hormone receptor ligands using QSAR and structure-based modeling methods.
Politi R; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2014 Oct; 280(1):177-89. PubMed ID: 25058446
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
Rosignolo F; Maggisano V; Sponziello M; Celano M; Di Gioia CR; D'Agostino M; Giacomelli L; Verrienti A; Dima M; Pecce V; Durante C
J Endocrinol Invest; 2015 Dec; 38(12):1283-9. PubMed ID: 26003825
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study.
Jerzak KJ; Cockburn JG; Dhesy-Thind SK; Pond GR; Pritchard KI; Nofech-Mozes S; Sun P; Narod SA; Bane A
Breast Cancer Res Treat; 2018 Oct; 171(3):709-717. PubMed ID: 29915948
[TBL] [Abstract][Full Text] [Related]
8. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone.
Kim S; Park S; Moon J; Kim H; Kang S
Ann Pediatr Endocrinol Metab; 2023 Sep; 28(3):219-224. PubMed ID: 37798897
[TBL] [Abstract][Full Text] [Related]
12. Truncated variants of thyroid hormone receptor beta display disease-inflicting malfunctioning at cellular level.
Rehman G; Kashyap J; Srivastav AK; Rizvi S; Kumar U; Tyagi RK
Exp Cell Res; 2024 Apr; 437(2):114017. PubMed ID: 38555013
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
14. The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro.
Vattai A; Ziegelmüller B; Kost B; Kuhn C; Hofmann S; Bayer B; Anslinger K; Jeschke U; Ditsch N
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():31-39. PubMed ID: 26476797
[TBL] [Abstract][Full Text] [Related]
15. Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality.
Sandsveden M; Borgquist S; Rosendahl AH; Manjer J
Breast Cancer Res; 2021 Dec; 23(1):117. PubMed ID: 34930399
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
Aljohani AI; Joseph C; Kurozumi S; Mohammed OJ; Miligy IM; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jun; 181(3):541-551. PubMed ID: 32350677
[TBL] [Abstract][Full Text] [Related]
18. Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway.
Brufsky AM
Breast J; 2014; 20(4):347-57. PubMed ID: 24861776
[TBL] [Abstract][Full Text] [Related]
19. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
Lundgren C; Bendahl PO; Ekholm M; Fernö M; Forsare C; Krüger U; Nordenskjöld B; Stål O; Rydén L
Breast Cancer Res; 2020 Dec; 22(1):140. PubMed ID: 33357231
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR
Mollon LE; Anderson EJ; Dean JL; Warholak TL; Aizer A; Platt EA; Tang DH; Davis LE
Clin Breast Cancer; 2020 Jun; 20(3):e232-e243. PubMed ID: 32234362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
